Mogamulizumab-kpkc Intravenous and Prograf (Tacrolimus Injection)
Determining the interaction of Mogamulizumab-kpkc Intravenous and Prograf (Tacrolimus Injection) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
Generic Name: tacrolimus
Brand name: Prograf, Astagraf XL, Envarsus XR, Hecoria
Synonyms: Prograf
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Mogamulizumab-kpkc Intravenous-Prograf Intravenous
- Mogamulizumab-kpkc Intravenous-Prohance
- Mogamulizumab-kpkc Intravenous-ProHance Injection
- Mogamulizumab-kpkc Intravenous-Prohist LQ
- Mogamulizumab-kpkc Intravenous-Prolensa
- Mogamulizumab-kpkc Intravenous-Prolensa ophthalmic
- Prograf (Tacrolimus Injection)-Molindone
- Prograf (Tacrolimus Injection)-Mometasone (Oral Inhalation)
- Prograf (Tacrolimus Injection)-Mometasone and Formoterol
- Prograf (Tacrolimus Injection)-Mometasone and formoterol Inhalation
- Prograf (Tacrolimus Injection)-Mometasone Cream
- Prograf (Tacrolimus Injection)-Mometasone Furoate